Carisma Therapeutics, Inc. financial statements
Carisma Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2024
| Revenue | USD 19.63M | EODHD |
| Net income | −USD 60.48M | EODHD |
| Cash and equivalents | USD 17.91M | EODHD |
| Total debt | USD 2.48M | EODHD |
Carisma Therapeutics, Inc. financials on 6ix · Carisma Therapeutics, Inc. on 6ix